Lately, there is an escalation in the number of medical cases due to an unhealthy lifestyle, absence of physical workouts, and non-conventional food habits. This makes the Indian wellness industry, a very big prospect in terms of revenue and target market. India has an unmatched heritage represented by its ancient systems of medicine. Indian systems of medicine and homoeopathy particularly Ayurveda and Yoga are widely recognised for their comprehensive approach to health and are effective in both prevention as well as curation of a disease.
India is the second largest exporter of Ayurvedic and alternative medicine in the world with the wellness market of worth INR 490 Billion. The demand for Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) and herbal products is surging in India and abroad. India has 6200 indigenous herbal plants and its vast reservoir of natural flora, fauna, ancient texts and knowledge have made it an authority in the field of AYUSH. The country’s vast AYUSH infrastructure comprises of 736,538 registered practitioners, 26,107 dispensaries and 3167 hospitals in public sector, 501 undergraduate colleges with annual intake of 28,018 students, 151 centres for postgraduate[ education with annual admission of 3504 scholars and 8896 licensed drug manufacturing units.
The Government of India has set up a dedicated Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) with the aim of providing stimulus to the ancient healthcare system. The Indian system of Ayurvedic medicine and homoeopathy continue to be widely used. The recent patents filed in the wellness industry in India are:
Title: SYSTEMS METHODS AND ARTICLES FOR ENHANCING WELLNESS ASSOCIATED WITH HABITABLE ENVIRONMENTS
Assignee: DELOS LIVING LLC
Publication Date: 20 Jan 2017
Environmental characteristics of habitable environments (e.g. hotel or motel rooms spas resorts cruise boat cabins offices hospitals and/or homes apartments or residences) are controlled to eliminate reduce or ameliorate adverse or harmful aspects and introduce increase or enhance beneficial aspects in order to improve a “wellness” or sense of “wellbeing” provided via the environments. Control of intensity and wavelength distribution of passive and active Illumination addresses various issues symptoms or syndromes for instance to maintain a circadian rhythm or cycle adjust for “jet lag” or season affective disorder etc.. Air quality and attributes are controlled. Scent(s) may be dispersed. Noise is reduced and sounds (e.g. masking music natural) may be provided. Environmental and biometric feedback is provided. Experimentation and machine learning are used to improve health outcomes and wellness standards.
Title: A SYSTEM AND METHOD FOR REAL TIME ASSESSMENT OF WELLNESS AND HEALTH INSURANCE
Assignee: eExpedise Technologies Private Limited
Publication Date: 4 Aug 2017
The present invention provides an integrated system to expedite the risk assessment process at the time of issuance of policy, and determine the premium based on several preventive care initiatives of individuals at the time of issuing health insurance policy, wherein the system identifies list of options for services, provides a score, makes a decision on issuance of policy, calculates the premium amount and relays the information to a user or proposer. Further, the system provides services selected from the group consisting of details of service provider, underwriting, claim adjudication, suspicious profile management, wellness advisory, predictive analysis, cost of the service based on health records and the user selects at least one option from provided list of options.
Title: METHOD FOR STRESS MANAGEMENT AND OVERALL HEALTH STATUS IMPROVEMENT AND COMPOSITIONS USED THEREIN
Assignee: OMNIACTIVE HEALTH TECHNOLOGIES LIMITED
Publication Date: 10 Nov 2017
Carotenoid compositions are described for management treatment and/or prevention of stress by reducing cortisol levels and/or improving distribution and/or density of macular pigment and thus improving overall health status. More particularly a subject in need thereof for the method has disturbed macular pigment optical density or increased levels of cortisol as markers of psychological and physiological stress. Methods are also described of administering macular carotenoid compositions in daily doses of at least or about 0.005mg/kg body weight of lutein and at least or about 0.001mg/kg body weight of meso zeaxanthin and zeaxanthin isomer along with at least one food grade excipient and evaluating overall health status. The composition may be derived from plant extract containing xanthophylls and/or xanthophylls esters. The composition also reduces cortisol levels in the blood and relieves physiological stress thus improving overall health status of a subject in need thereof.
Title: SYSTEM, DEVICE AND METHOD FOR REMOTELY MONITORING THE WELL BEING OF A USER WITH A WEARABLE DEVICE
Assignee: KONINKLIJKE PHILIPS N.V
Publication Date: 6 Oct 2017
Systems devices methods for providing a speech pattern as a metric of well being system for remotely monitoring the wellbeing of a patient are disclosed. In one exemplary embodiment a system can include at least one wearable device that is configured to collect body sensor data and speech pattern data associated with a patient wearing the device and analyze the data to determine if the patient’s emotional well being is compromised. In some exemplary embodiments the wearable device can be configured to send an alert to at least one caregiver device that indicates the patient’s emotional well being is compromised. The wearable device can also be configured to send recommendations on courses of action to alleviate the condition.
Title: BEHAVIORAL ANALYSIS TO AUTOMATE DIRECT AND INDIRECT LOCAL MONITORING OF INTERNET OF THINGS DEVICE HEALTH
Assignee: QUALCOMM INCORPORATED
Publication Date: 29 Sept 2017
The disclosure generally relates to behavioral analysis to automate monitoring Internet of Things (IoT) device health in a direct and/or indirect manner. In particular normal behavior associated with an IoT device in a local IoT network may be modeled such that behaviors observed at the IoT device may be compared to the modeled normal behavior to determine whether the behaviors observed at the IoT device are normal or anomalous. Accordingly in a distributed IoT environment more powerful “analyzer” devices can collect behaviors locally observed at other (e.g. simpler) “observer” devices and conduct behavioral analysis across the distributed IoT environment to detect anomalies potentially indicating malicious attacks malfunctions or other issues that require customer service and/or further attention. Furthermore devices with sufficient capabilities may conduct (local) on device behavioral analysis to detect anomalous conditions without sending locally observed behaviors to another aggregator device and/or analyzer device.
Title: EXERCISE DEVICE
Assignee: TE3 OY
Publication Date: 17 Nov 2017
The invention relates to a device (100) for performing exercises comprising a housing (105) a deviation sensor (140) for detecting a deviation of said housing (105) from an equilibrium and a control unit (110) coupled to said deviation sensor (140) arranged to count deviations from the equilibrium.
Title: METHOD AND SYSTEM FOR REAL TIME VISUALIZATION OF INDIVIDUAL HEALTH CONDITION ON A MOBILE DEVICE
Assignee: RATH Matthias W.
Publication Date: 24 Nov 2017
A method and technology to display 3D graphical output for a user using body sensor data personal medical data in real time is disclosed. A consolidated methodology to bring user meaningful life information based on real time sensor results analysis expert Q&As “What if scenarios and future emulation all in one artificial intelligence expert system is described. A unique rendering of 3D image of ones organ cell or subcellular level display related to one’s health condition can be visualized on a graphical user interface of a devices or devices. The change of the display from one level such as from organ to cell or cell to subcellular level or vice versa is enabled is disclosed.
Food Processing Sector-“priority sector” in India’s Make in India Programme
India is one of the quickest growing economies in the world. India has climbed 30 ranks in the World Bank’s ease of doing Business rankings 2017 and was ranked number 1 in the world in 2016 in greenfield investment. The government of India is undertaking a range of transformational initiatives as a result of which India is also rapidly progressing on the Global Innovation Index, Global Logistics Index and Global Competitiveness Index. World Food India (WFI) was a gateway to the Indian food economy and an opportunity to showcase, connect, and collaborate.
“World Food India 2017”
A global event to facilitate partnerships between Indian and international businesses and investors held in India from 3rd Nov 2017 to 5th Nov 2017. World Food India 2017 was organized by the Ministry of Food Processing Industries, Government of India and was inaugurated by Honourable Prime Minister Narendra Modi at Vigyan Bhavan in New Delhi on 3rd Nov 2017. World Food India 2017 hosted the largest gathering of investors, manufacturers, producers, food processors, policy makers, and organizations from the global food ecosystem to provides opportunities for both investment and trade in the food processing sector for leading Indian and International companies.
Food Processing Sector is the”priority sector” in India’s Make in India Programme. India is now the most preferred investment destination in the Food processing Sector because 100% Foreign Direct Investment (FDI) is now permitted, for trading, including via e-commerce, of food products manufactured in India. As an incentive from the Union and state governments, it has become very easy to obtain loans for food and agro-based processing units, and cold chains at low Interest Rates.
Nivesh Bandhu or investor’s friend is a one of its kind portal launched by Government of India to bring together information on Central and State Government policies and incentives provided for the food processing sector. It is also a platform for business networking, for farmers, processors, traders, and logistics operators.
COMBATING MOSQUITO BORNE DISEASES”- A brilliant idea for healthcare business in India
Healthcare industry in India has come a long way in terms of advancement.Although healthcare in India is showing a gradual progress, there are still millions of opportunities to create an evolving business by tackling the major challenges of the mass population.
With regard to mosquito-borne diseases, the world’s consideration has been focused on Zika for as far back as a year.
Be that as it may, different ailments like malaria or dengue still debilitate more individuals. Dengue and chikungunya are mosquito-borne ailments that are as of now re-rising as general wellbeing loads around the world. Every year, more than 390 million individuals are tainted with dengue, while chikungunya occasionally develops in exceedingly populated regions.
Mosquitoes transmit the causative specialists for a few irresistible maladies that can be destructive to people. The fast advancement of mosquitoes and their brisk reaction to changing conditions make mosquitoes a standout amongst the most troublesome creepy crawlies to balance.
“It is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change.” – Charles Darwin
Malaria is the most destructive parasitic illness spread by mosquitoes. Malaria is transmitted to people through bite of female Anopheles mosquitoes. The deadly parasite, Plasmodium, which is transmitted to people by the mosquito, incorporates high fever, serious cerebral pains, insanity, and perplexity. About 1 million malaria cases are accounted for every year in India. The majority of the malaria cases originate from six states- Orissa, Chhattisgarh, Jharkhand, Meghalaya, Arunachal Pradesh and Mizoram.
India has mapped out the arrangement to wipe out malaria by 2027 which is three years before the worldwide malaria disposal design of WHO- “WHO Global Technical Strategy for Malaria 2016– 2030”.
“Health care and education are too important NOT to be left to the free market.” ― Kevin D. Williamson
Sigtuple, a Bengaluru based startup in India is helping hospitals and healthcare centres improve the speed and accuracy of blood reports. They have developed AI-powered Manthana platform, which can analyze blood samples and generate medical reports in less than 10 minutes—and with complete accuracy. This Manthana platform is being used by a number of mid- to large-sized hospitals and diagnostics labs to catch Plasmodium, the parasite that causes malaria for early detection of Malaria.
“Give people what they need: food, medicine, clean air, pure water, trees and grass, pleasant homes to live in, some hours of work, more hours of leisure. Don’t ask who deserves it. Every human being deserves it.” ― Howard Zinn
Zika infection is spread by daytime-dynamic Aedes mosquitoe, a similar that spreads dengue and chikungunya.
It can cause a gentle sickness, with fever, rash, and joint agony. Be that as it may, disease amid pregnancy can prompt serious mind related birth deserts in babies. It is described by cerebrum harm and may cause different imperfections like visual impairment, deafness, and even seizures.
A few cases of Zika infection have been identified in India but India has no vaccine or cure for Zika virus infection.
European Patent Application EP3184118 relates to a recombinant vaccine against Zika virus. This patent was filed on 29th March 2016 by Themis Bioscience GmbH.
WIPO Patent Application WO/2017/142807, filed on 10th February 2017 by TAMIR BIOTECHNOLOGY, INC relates to treatment or prevention of Zika virus infections by administration of a ribonuclease.
United States Patent Application US20170216246, filed on 31st January 2017, by Lines, Thomas Christian pertains to a method for treating Zika virus infection with a composition containing quercetin or isoquercetin, together with one or more of vitamin B3, vitamin C, and a folate compound is described. Methods of preventing microcephaly and treating and preventing infections of other Flavivridae viruses are also described.
Indian startups have great energy, thought-process and leadership to tackle this challenge and come up with a system or method for detection and treatment of Zika virus infection.
DENGUE and CHIKUNGUNYA
The incidence of Mosquito borne diseases like Dengue and Chikungunya in has seen an upsurge over the past few years in India. Chikungunya and Dengue both spread through the bite of the Aedes aegypti mosquito..
Dengue is caused by one of four firmly related yet antigenically different flavivirus (DEN-1, DEN-2, DEN-3 and DEN-4). Symptoms include high fever, extreme frontal migraine, torment behind the eyes, muscle and joint torments, with or without measles-like rash and sickness which in extreme situation can cause hemorrhage and multi-organ failure.
“The world today has 6.8 billion people. That’s heading up to about nine billion. Now if we do a really great job on new vaccines, health care & reproductive health services, we could LOWER that by perhaps 10 or 15 percent.” ― Bill Gates
Sanofi Pasteur built up the world’s first dengue antibody, Dengvaxia®. It is a tetravalent dengue antibody, for the avoidance of infection caused by every one of the four dengue sorts in people from 9-45 years old living in endemic territories.
Symptoms of Chikungunya include- migraine, fever, weakness, queasiness, heaving, muscle torment and extreme joint torment. There is no vaccine available against Chikungunya in India and symptomatic treatment is utilized to treat throbs and fever. Chikungunya doesn’t kill yet causes extreme and agonizing appendage disfigurement that may last a long time.
“Our primary health care should begin on the farm and in our hearts, and not in some laboratory of the biotech and pharmaceutical companies.” ― Gary Hopkins
Bharat Biotech, a Hyderabad based company developed Chikungunya vaccine in India. The vaccine is in the early stage of human clinical trials.
Further, Sun Pharma will give its medication particles to National Institute of Virology (NIV), India to test on Zika, chikungunya, and dengue. The medications demonstrating promising outcomes will be taken further for business improvement.
Sun Pharma is focused on developing medications and antibodies against the rising circumstance of arboviruses comprehensively.
The joint effort of Sun Pharma and National Institute of Virology is in a state of harmony with the administration’s ‘Make in India’ activity. Together they plan to lead joint logical research and advancement to test drugs, biosimilars, antibodies and ailment control and end programs.
Sun Pharma inked another settlement with International Center for Genetic Engineering and Biotechnology (ICGEB) for the advancement of sheltered, powerful, and reasonable “Made in India” vaccine against dengue- DSV4. DSV4 is a recombinant Virus like Particle (VLPs) based vaccine.
Startups and budding entrepreneurs can come up with methods and devices that utilize robots or automation for early detection of mosquito-borne diseases.
Patents of some high priced drugs and vaccines are set to expire soon and some patents are already in the public domain. The development of biosimilars to these biologics can provide some affordable drugs for the treatment of these critical diseases. If you are a pharmaceutical business entity in India and want to explore the amazing field of utilizing expired patents in medicine sector contact us today to discuss your business goal with our team of Thinking Geeks.
We at TCIS (Tech Corp International Strategist), India help in providing market research analysis for the leading technologies in the market. We have vast experience in Share Market, Stock Market, Finance, Business Development, Marketing & sales.
To know more, schedule a call today we are always ready to help you.
Aarti Dhillon is a third-year law student pursuing BBA LLB (Hons.) with specialization in corporate laws from the College of Legal Studies, University of Petroleum and Energy studies. She is an enthusiastic individual with an emphasis on achieving astounding standards both personally and academically. She is an aspiring corporate law and patent law enthusiast who is captivated with exploring, learning and practicing technology, invention, business, and law simultaneously. In her opinion Law, business and technology have reliably been the thing that has intrigued her the most and how with genuine learning and practice with regards to the said three, one can organize the framework to oblige individuals’ individual needs. She plans to have an effective law career ahead and apply her aptitudes obtained from both her work and academic experience and further enable her to make a difference in people’s life.